The involvement of miRNAs in synthetic lethality [19, 42] has also been recently described in retinoblastoma, where the inactivation of a miR-17-92 cluster has a synthetic lethal interaction with RB/p53 pathways, resulting in the suppression of tumor formation [43]. This evidence concerns the gene RB1 and retinoblastoma.